Lv71
4390 积分 2022-03-25 加入
Bispecific antibodies
1个月前
已完结
The making of multispecific immunoglobulins – a clinical perspective
1个月前
已完结
The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
1个月前
已完结
Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody
1个月前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
2个月前
已完结
ABBV-303 Is an NK-cell Engager Specific for c-Met-Expressing Tumors
2个月前
已完结
BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease
3个月前
已完结
皖公网安备34019202002308
